Sign in

NCT02246725Completed

Observational Study of Early Contact With Palliative Care Unit for Patients Receiving First Line Palliative Chemotherapy With Cancer in Upper Gastrointestinal Canal, or Second Line Palliative Chemotherapy in Patients With Colorectal Cancer - an Open, Randomised Investigator Initiated Trial.

Source: ClinicalTrials.gov · Last updated 12 Sept 2025

Brief summary (registry, in English)

In this trial, patients with cancer in the upper gastrointestinal canal who are going to receive first line palliative chemotherapy and patients with colorectal cancer who are going to receive second line palliative chemotherapy will be included. Participating patients will be randomized between early contact with a palliative care unit, or contact with a palliative care unit when needed. The objectives with the trial is to investigate if an early establishment with a palliative care unit will have a positive impact on the patients quality of life, this also applies for the nearest relative, survival, and if a difference in numbers of chemotherapy cycles can be detected.

Status (registry)
Completed
Study type
Observational
Enrollment
108 (actual)
First submitted
19 Sept 2014
Start date
1 Oct 2014
Primary completion date
31 Aug 2025
Lead sponsor
Lund University Hospital
NCT number
NCT02246725

What you commit to

  • Study type: Observational
  • Participants enrolled: 108
  • From 1 Oct 2014 to the primary completion date, 31 Aug 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Patients with already ongoing chemotherapy

Other

  • Patients with neuroendocrine tumor
  • Patients with already established contact with palliative care unit

Who the study is looking for

  • Patients with tumor in upper gastrointestinal canal, who is going to start treatment with first line palliative chemotherapy
  • Patients with colorectal cancer, who is going to start treatment with second line palliative chemotherapy
  • Signed written informed concent

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Lund University Hospital
Coordinator of this site? Confirm its status
LundSwedenUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.